Vernekar Sunil S, Goudar Swati S, Metgud Mrityunjay, Pujar Yeshita V, Somannavar Manjunath S, Piaggio Gilda, Carvalho José Ferreira D E, Revankar Amit, Althabe Fernando, Widmer Mariana, Gulmezoglu Ahmet Metin, Goudar Shivaprasad S
Women's and Children's Health Research Unit, J N Medical College, KLE Academy of Higher Education and Research, Belagavi, India.
Obstetrics and Gynaecology, Amrita Institute of Medical Sciences, Kochi, India.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):8744-8751. doi: 10.1080/14767058.2021.2001799. Epub 2021 Nov 11.
To compare the effect of heat-stable carbetocin 100 μg IM versus oxytocin 10 IU IM on post-delivery hemoglobin level.
Hospital based study in Southern India.
Women delivering vaginally who were enrolled in the WHO CHAMPION trial in a single facility in India. WHO CHAMPION Trial was a randomized, double-blind, noninferiority trial comparing intramuscular injections of heat-stable carbetocin with oxytocin administered immediately after vaginal birth in women across 23 sites in 10 countries.
This was a nested randomized controlled trial designed to compare the effect of heat-stable carbetocin 100 μg IM versus oxytocin 10 IU IM, administered within one minute of vaginal delivery of the baby for prevention of postpartum hemorrhage, on post-delivery 48-72 h hemoglobin level, adjusted for pre-delivery hemoglobin level. 1,799 women from one hospital in India participated in this study.
Pre-delivery hemoglobin and postpartum blood loss were not significantly different between carbetocin and oxytocin. Post-delivery hemoglobin, unadjusted or adjusted for pre-delivery hemoglobin, was slightly lower for carbetocin (10.09 g/dL) compared to oxytocin (10.21) (p value of 0.0432). The drop in hemoglobin was slightly higher for carbetocin, although the difference was very small (1.2 g/dL for carbetocin, 1.1 g/dL for oxytocin) ( value of .0786). The proportion of participants with a drop in hemoglobin of 2 g/dL or more, adjusted for pre-delivery hemoglobin, was higher for carbetocin (RR = 1.29, 95% CI 1.02-1.63). From the regression coefficients it can be derived that post-delivery hemoglobin, adjusted for pre-delivery hemoglobin, decreases on average 0.12 g/dL for each dL of blood lost, for the two treatments combined.
The present ancillary study showed that intramuscular administration of 100 µg of heat stable carbetocin can result in a slightly lower post-delivery hemoglobin, slightly higher drop and higher percentage of women having a drop of 2 g/dL or larger, compared to 10 IU of oxytocin.
比较100μg肌内注射热稳定卡贝缩宫素与10IU肌内注射缩宫素对产后血红蛋白水平的影响。
印度南部基于医院的研究。
在印度一家机构参加世界卫生组织CHAMPION试验的经阴道分娩的妇女。世界卫生组织CHAMPION试验是一项随机、双盲、非劣效性试验,比较了在10个国家23个地点对经阴道分娩的妇女立即肌内注射热稳定卡贝缩宫素与缩宫素的效果。
这是一项嵌套随机对照试验,旨在比较在婴儿经阴道分娩后1分钟内肌内注射100μg热稳定卡贝缩宫素与10IU肌内注射缩宫素预防产后出血对产后48 - 72小时血红蛋白水平的影响,并根据分娩前血红蛋白水平进行调整。来自印度一家医院的1799名妇女参与了本研究。
卡贝缩宫素组和缩宫素组在分娩前血红蛋白水平和产后失血量方面无显著差异。未调整或根据分娩前血红蛋白水平调整后的产后血红蛋白水平,卡贝缩宫素组(10.09g/dL)略低于缩宫素组(10.21g/dL)(p值为0.0432)。卡贝缩宫素组血红蛋白下降幅度略高,尽管差异非常小(卡贝缩宫素组为1.2g/dL,缩宫素组为1.1g/dL)(p值为0.0786)。根据分娩前血红蛋白水平调整后,血红蛋白下降2g/dL或更多的参与者比例,卡贝缩宫素组更高(RR = 1.29,95%CI 1.02 - 1.63)。从回归系数可以得出,对于两种治疗方法合并而言,根据分娩前血红蛋白水平调整后的产后血红蛋白水平,每失血1dL平均下降0.12g/dL。
本辅助研究表明,与10IU缩宫素相比,肌内注射100μg热稳定卡贝缩宫素可导致产后血红蛋白水平略低、下降幅度略高,且血红蛋白下降2g/dL或更多的妇女百分比更高。